More articles from WHO News Release

Open Access
WHO PREQUALIFIES DIAGNOSTIC TEST TO SUPPORT SAFER ADMINISTRATION OF P. VIVAX MALARIA TREATMENTS
Neurosciences Journal April 2025, 30 (2) 167-168;
Open Access
MILESTONE: COVID-19 FIVE YEARS AGO
Neurosciences Journal April 2025, 30 (2) 167;
Open Access
MEASLES CASES SURGE WORLDWIDE, INFECTING 10.3 MILLION PEOPLE IN 2023
Neurosciences Journal January 2025, 30 (1) 73-74;
Open Access
WHO ADDS LC16M8 MPOX VACCINE TO EMERGENCY USE LISTING
Neurosciences Journal January 2025, 30 (1) 74-75;
Open Access
OPEN ACCESS WHO DIRECTOR-GENERAL DECLARES MPOX OUTBREAK A PUBLIC HEALTH EMERGENCY OF INTERNATIONAL CONCERN
Neurosciences Journal October 2024, 29 (4) 298-299;
Open Access
WHO PREQUALIFIES THE FIRST SELF-TEST FOR HEPATITIS C VIRUS
Neurosciences Journal October 2024, 29 (4) 299-300;
Open Access
STRENGTHENED GLOBAL CAPACITIES ON CLIMATE CHANGE AND HEALTH: WHO TRAINING IN MADRID
Neurosciences Journal July 2024, 29 (3) 212-213;
Open Access
WHO REPORTS WIDESPREAD OVERUSE OF ANTIBIOTICS IN PATIENTS HOSPITALIZED WITH COVID-19
Neurosciences Journal July 2024, 29 (3) 213-214;
Open Access
Urgent action needed to protect children and prevent the uptake of e-cigarettes
Neurosciences Journal April 2024, 29 (2) 148-149;
Open Access
WHO prequalifies a second malaria vaccine, a significant milestone in prevention of the disease
Neurosciences Journal April 2024, 29 (2) 149-150;

Pages